Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6452112rdf:typepubmed:Citationlld:pubmed
pubmed-article:6452112lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6452112lifeskim:mentionsumls-concept:C0558355lld:lifeskim
pubmed-article:6452112lifeskim:mentionsumls-concept:C0038856lld:lifeskim
pubmed-article:6452112lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:6452112pubmed:issue1lld:pubmed
pubmed-article:6452112pubmed:dateCreated1981-5-13lld:pubmed
pubmed-article:6452112pubmed:abstractTextThe follow-up of suppressor cell activity in patients with squamous cell carcinoma of the tonsil seems to give anew insight into the clinical situation of a patient. In 54 patients with tonsillar carcinoma followed over 3 years, regulator cells, i.e., suppressor cells, have been investigated. The patients with bad clinical conditions show continuous increase with suppressor activity already at the time of operation, especially in cultures with activated suppressor cells. The new therapeutical treatment of cancer patients should be directed in such a way that the unfavourable suppressor cell be eliminated while the cytotoxic effector cell be stimulated.lld:pubmed
pubmed-article:6452112pubmed:languageenglld:pubmed
pubmed-article:6452112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6452112pubmed:citationSubsetIMlld:pubmed
pubmed-article:6452112pubmed:statusMEDLINElld:pubmed
pubmed-article:6452112pubmed:issn0302-9530lld:pubmed
pubmed-article:6452112pubmed:authorpubmed-author:HammerCClld:pubmed
pubmed-article:6452112pubmed:authorpubmed-author:GruberFFlld:pubmed
pubmed-article:6452112pubmed:authorpubmed-author:MangW LWLlld:pubmed
pubmed-article:6452112pubmed:issnTypePrintlld:pubmed
pubmed-article:6452112pubmed:volume230lld:pubmed
pubmed-article:6452112pubmed:ownerNLMlld:pubmed
pubmed-article:6452112pubmed:authorsCompleteYlld:pubmed
pubmed-article:6452112pubmed:pagination21-6lld:pubmed
pubmed-article:6452112pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:meshHeadingpubmed-meshheading:6452112-...lld:pubmed
pubmed-article:6452112pubmed:year1981lld:pubmed
pubmed-article:6452112pubmed:articleTitleSuppressor cell activity in patients with tonsillar carcinoma.lld:pubmed
pubmed-article:6452112pubmed:publicationTypeJournal Articlelld:pubmed